Figure S1 from Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung Cancer
Gonzálo Recondo,Laura Mezquita,Francesco Facchinetti, David Planchard,Anas Gazzah,Ludovic Le Bigot,Ahsan Z. Rizvi,Rosa L. Frias,Jean Paul Thiery,Jean‐Yves Scoazec,Tony Sourisseau,Karen Howarth,Olivier Déas,Dariia Samofalova,Justine Galissant, Pauline Tesson,Floriane Brayé,Charles Naltet,Pernelle Lavaud,Linda Mahjoubi,Aurélie Abou Lovergne,Gilles Vassal,Rastilav Bahleda,Antoine Hollebecque,Claudio Nicotra,Maud Ngo-Camus, Stefan Michiels, Ludovic Lacroix,Catherine Richon,Nathalie Auger,Thierry De Baère,Lambros Tselikas,Éric Solary,Eric Angevin,Alexander Eggermont,Fabrice André,Christophe Massard,Ken A. Olaussen, Jean‐Charles Soria,Benjamin Besse,Luc Friboulet openalex（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper